KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ACM Research (ACMR) Asset Writedowns and Impairment (2023 - 2025)

Historic Asset Writedowns and Impairment for ACM Research (ACMR) over the last 3 years, with Q3 2025 value amounting to $8.0 million.

  • ACM Research's Asset Writedowns and Impairment rose 10942.22% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 14948.51%. This contributed to the annual value of $13.5 million for FY2024, which is 39314.12% up from last year.
  • Latest data reveals that ACM Research reported Asset Writedowns and Impairment of $8.0 million as of Q3 2025, which was up 10942.22% from $1.4 million recorded in Q2 2025.
  • ACM Research's 5-year Asset Writedowns and Impairment high stood at $8.0 million for Q3 2025, and its period low was -$9000.0 during Q1 2025.
  • Over the past 3 years, ACM Research's median Asset Writedowns and Impairment value was $1.1 million (recorded in 2023), while the average stood at $2.3 million.
  • In the last 5 years, ACM Research's Asset Writedowns and Impairment surged by 60254.78% in 2024 and then tumbled by 10076.86% in 2025.
  • Quarter analysis of 3 years shows ACM Research's Asset Writedowns and Impairment stood at $1.1 million in 2023, then surged by 602.55% to $7.7 million in 2024, then rose by 4.21% to $8.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $8.0 million for Q3 2025, versus $1.4 million for Q2 2025 and -$9000.0 for Q1 2025.